Yahoo Finance

Signifier Medical Introduces New eXciteOSA® Product Update, Expanding Access to Sleep Apnea Therapy for More Medicare and Medicaid Patients

LONDON, March 06, 2025--(BUSINESS WIRE)--Signifier Medical Technologies Limited ("Signifier"), a global leader in medical technology for sleep-disordered breathing, today announced the introduction of ...
pharmaphorum

FDA approves Signifier's obstructive sleep apnoea device

The FDA has approved Signifier Medical Technologies’ prescription-only device eXciteOSA, which uses electrical muscle stimulation to treat obstructive sleep apnoea (OSA). In a statement, the regulator ...
Yahoo Finance

Signifier Medical Technologies Secures European Union Medical Device Regulation (EU MDR) Certification for eXciteOSA®

LONDON, February 05, 2025--(BUSINESS WIRE)--Signifier Medical Technologies Limited ("Signifier"), a global leader in medical technology for sleep-disordered breathing, announces that it has achieved ...
Business Wire

Signifier Medical Technologies Announces Upcoming Publication of Randomized Controlled Trial Results Examining High-Intensity (Active) Vs. Low-Intensity (Sham) Neuromuscular ...

BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies LLC (“Signifier” or the “Company”), a Boston-based medical technology company, is pleased to announce that the publication of AEGIS ...
Business Wire

Signifier Medical Ushers In New Era of Treatment for Sleep Apnea and Snoring with FDA Approval of eXciteOSA Device

Revolutionary first-ever daytime treatment for mild obstructive sleep apnea and snoring will now be available in the United States BOSTON & LONDON--(BUSINESS WIRE)--Signifier Medical Technologies, an ...
VentureBeat

Signifier Medical Technologies Raises $35M in Series D Funding Round to Accelerate Commercialization of eXciteOSA Therapy

Signifier Medical Technologies Ltd, a pioneer in patient-friendly therapies for sleep disordered breathing, announced that it has successfully raised $35 million in its Series D capital raise. This ...